{"transactions":[{"id":672776,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-28T21:01:49.000Z","date":"2026-08-28","kind":"purchase","planned":false,"acquired":true,"shares":4843,"price":2.16,"value":10460.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Common Stock were purchased in several open market transactions, all at the same price. The reported price does not reflect a weighted average price."}],"balance_after":6036,"source":{"system":"sec-edgar","filing":"0001520138-26-000383","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013826000383/ownership.xml","form_type":"4"}},{"id":673184,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18813,"kind":"person","name":"Chappell Amy Suzon","position":1,"cik":"0002090156","reported_name":"Chappell Amy Suzon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-28T21:01:21.000Z","date":"2026-08-28","kind":"purchase","planned":false,"acquired":true,"shares":727,"price":2.16,"value":1570.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock were purchased by the Reporting Person in an open market transaction."}],"balance_after":727,"source":{"system":"sec-edgar","filing":"0001520138-26-000382","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2090156/000152013826000382/ownership.xml","form_type":"4"}},{"id":672771,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-28T20:58:13.000Z","date":"2026-08-28","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.18,"value":5450.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock were purchased by the Reporting Person in an open market transaction."}],"balance_after":3441,"source":{"system":"sec-edgar","filing":"0001520138-26-000379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013826000379/ownership.xml","form_type":"4"}},{"id":672929,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-28T20:57:40.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":15210,"price":2.08,"value":31636.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price at which shares were purchased in several open market transactions on August 27, 2026, at prices ranging from $2.05 to $2.10, inclusive. The reporting person undertakes to provide BioVie Inc., any stockholder of BioVie Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":16117,"source":{"system":"sec-edgar","filing":"0001520138-26-000378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013826000378/ownership.xml","form_type":"4"}},{"id":941839,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T22:03:29.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":132000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"55% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029"}],"balance_after":132000,"derivative":{"exercise_price":1.31,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":132000},"source":{"system":"sec-edgar","filing":"0001520138-26-000024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013826000024/ownership.xml","form_type":"4"}},{"id":941838,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T22:03:04.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":110100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"55% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029."}],"balance_after":110100,"derivative":{"exercise_price":1.31,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":110100},"source":{"system":"sec-edgar","filing":"0001520138-26-000023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013826000023/ownership.xml","form_type":"4"}},{"id":942075,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T22:02:23.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":665300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"55% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":665300,"derivative":{"exercise_price":1.31,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":665300},"source":{"system":"sec-edgar","filing":"0001520138-26-000021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013826000021/ownership.xml","form_type":"4"}},{"id":942490,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":21766,"kind":"person","name":"Farag Kameel D.","position":1,"cik":"0002093620","reported_name":"Farag Kameel D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T22:01:17.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"7,500 shares of the underlying options vest s on grant date and the remaining balance in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting."}],"balance_after":57500,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"COMMON STOCK","underlying_shares":57500},"source":{"system":"sec-edgar","filing":"0001520138-26-000019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2093620/000152013826000019/ownership.xml","form_type":"4"}},{"id":941837,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T22:00:32.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":330500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029."}],"balance_after":330500,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":330500},"source":{"system":"sec-edgar","filing":"0001520138-26-000017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013826000017/ownership.xml","form_type":"4"}},{"id":941836,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T22:00:32.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments on February 10, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting."}],"balance_after":90000,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001520138-26-000017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013826000017/ownership.xml","form_type":"4"}},{"id":942521,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69700,"kind":"person","name":"ROGICH SIGMUND","position":1,"cik":"0001168218","reported_name":"ROGICH SIGMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T17:02:46.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":141100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029."}],"balance_after":141100,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":141100},"source":{"system":"sec-edgar","filing":"0001520138-26-000022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168218/000152013826000022/ownership.xml","form_type":"4"}},{"id":942520,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69700,"kind":"person","name":"ROGICH SIGMUND","position":1,"cik":"0001168218","reported_name":"ROGICH SIGMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T17:02:46.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting."}],"balance_after":70000,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001520138-26-000022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168218/000152013826000022/ownership.xml","form_type":"4"}},{"id":942156,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69667,"kind":"person","name":"Sherman Michael Edward","position":1,"cik":"0001730468","reported_name":"Sherman Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T17:01:46.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":341100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029."}],"balance_after":341100,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":341100},"source":{"system":"sec-edgar","filing":"0001520138-26-000020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730468/000152013826000020/ownership.xml","form_type":"4"}},{"id":942155,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69667,"kind":"person","name":"Sherman Michael Edward","position":1,"cik":"0001730468","reported_name":"Sherman Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T17:01:46.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting."}],"balance_after":80000,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001520138-26-000020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730468/000152013826000020/ownership.xml","form_type":"4"}},{"id":942489,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18813,"kind":"person","name":"Chappell Amy Suzon","position":1,"cik":"0002090156","reported_name":"Chappell Amy Suzon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T17:00:55.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"7,500 shares underlying the options vest on grant date and the remaining balance will vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting."}],"balance_after":57500,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":57500},"source":{"system":"sec-edgar","filing":"0001520138-26-000018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2090156/000152013826000018/ownership.xml","form_type":"4"}},{"id":1067710,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Warrants (right to buy)","published_at":"2025-08-13T20:05:17.000Z","date":"2025-08-07","kind":"purchase","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $2.00 in connection with the issuer's public offering that closed on August 11, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":5050,"derivative":{"exercise_price":2.5,"exercise_date":"2025-08-11","expiration_date":"2030-08-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520138-25-000251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013825000251/ownership.xml","form_type":"4"}},{"id":1067709,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-08-13T20:05:17.000Z","date":"2025-08-07","kind":"purchase","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $2.00 in connection with the issuer's public offering that closed on August 11, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":9992,"source":{"system":"sec-edgar","filing":"0001520138-25-000251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013825000251/ownership.xml","form_type":"4"}},{"id":1307546,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:19:39.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":22690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."}],"balance_after":22690,"derivative":{"exercise_price":1.9,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":22690},"source":{"system":"sec-edgar","filing":"0001520138-25-000020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013825000020/ownership.xml","form_type":"4"}},{"id":1307545,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:19:39.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":61600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting."}],"balance_after":61600,"derivative":{"exercise_price":3.36,"expiration_date":"2029-11-20","underlying":"Common Stock","underlying_shares":61600},"source":{"system":"sec-edgar","filing":"0001520138-25-000020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013825000020/ownership.xml","form_type":"4"}},{"id":1307629,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:06:54.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":21815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."}],"balance_after":21815,"derivative":{"exercise_price":1.9,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":21815},"source":{"system":"sec-edgar","filing":"0001520138-25-000016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000152013825000016/ownership.xml","form_type":"4"}},{"id":1307628,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:06:54.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":49800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting."}],"balance_after":49800,"derivative":{"exercise_price":3.36,"expiration_date":"2029-11-20","underlying":"Common Stock","underlying_shares":49800},"source":{"system":"sec-edgar","filing":"0001520138-25-000016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000152013825000016/ownership.xml","form_type":"4"}},{"id":1307544,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:05:25.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":15417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."}],"balance_after":15417,"derivative":{"exercise_price":1.9,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":15417},"source":{"system":"sec-edgar","filing":"0001520138-25-000014","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013825000014/ownership.xml","form_type":"4"}},{"id":1307543,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:03:01.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":14417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."}],"balance_after":14417,"derivative":{"exercise_price":1.9,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":14417},"source":{"system":"sec-edgar","filing":"0001520138-25-000012","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013825000012/ownership.xml","form_type":"4"}},{"id":1307925,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:01:10.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":104502,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":104502,"derivative":{"exercise_price":1.9,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":104502},"source":{"system":"sec-edgar","filing":"0001520138-25-000010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013825000010/ownership.xml","form_type":"4"}},{"id":1308471,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69700,"kind":"person","name":"ROGICH SIGMUND","position":1,"cik":"0001168218","reported_name":"ROGICH SIGMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T17:26:37.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":22070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."}],"balance_after":22070,"derivative":{"exercise_price":1.9,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":22070},"source":{"system":"sec-edgar","filing":"0001520138-25-000026","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168218/000152013825000026/ownership.xml","form_type":"4"}},{"id":1308470,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69700,"kind":"person","name":"ROGICH SIGMUND","position":1,"cik":"0001168218","reported_name":"ROGICH SIGMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-07T17:26:37.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":32700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") grant, which was approved by the compensation committee of the issuer's board of directors, subject to board approval, which was obtained on November 20, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting."}],"balance_after":36926,"source":{"system":"sec-edgar","filing":"0001520138-25-000026","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168218/000152013825000026/ownership.xml","form_type":"4"}},{"id":1308533,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T17:24:53.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":23155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."}],"balance_after":23155,"derivative":{"exercise_price":1.9,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":23155},"source":{"system":"sec-edgar","filing":"0001520138-25-000024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000152013825000024/ownership.xml","form_type":"4"}},{"id":1308532,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-07T17:24:53.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") grant, which was approved by the compensation committee of the issuer's board of directors, subject to board approval, which was obtained on November 20, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting."}],"balance_after":40643,"source":{"system":"sec-edgar","filing":"0001520138-25-000024","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000152013825000024/ownership.xml","form_type":"4"}},{"id":1308131,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69667,"kind":"person","name":"Sherman Michael Edward","position":1,"cik":"0001730468","reported_name":"Sherman Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T17:21:05.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":23325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."}],"balance_after":23325,"derivative":{"exercise_price":1.9,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":23325},"source":{"system":"sec-edgar","filing":"0001520138-25-000022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730468/000152013825000022/ownership.xml","form_type":"4"}},{"id":1308130,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69667,"kind":"person","name":"Sherman Michael Edward","position":1,"cik":"0001730468","reported_name":"Sherman Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T17:21:05.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":56900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting."}],"balance_after":56900,"derivative":{"exercise_price":3.36,"expiration_date":"2029-11-20","underlying":"Common Stock","underlying_shares":56900},"source":{"system":"sec-edgar","filing":"0001520138-25-000022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730468/000152013825000022/ownership.xml","form_type":"4"}},{"id":1455172,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-12T22:02:10.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":156000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal annual installments beginning on June 24, 2024."}],"balance_after":156000,"derivative":{"exercise_price":0.474,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":156000},"source":{"system":"sec-edgar","filing":"0001520138-24-000241","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000241/ownership.xml","form_type":"4"}},{"id":1455171,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-07-12T22:02:10.000Z","date":"2024-06-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":29000,"price":0.474,"value":13746.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024."}],"balance_after":119196,"source":{"system":"sec-edgar","filing":"0001520138-24-000241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000241/ownership.xml","form_type":"4"}},{"id":1455170,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-07-12T22:02:10.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":116000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024."}],"balance_after":148196,"source":{"system":"sec-edgar","filing":"0001520138-24-000241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000241/ownership.xml","form_type":"4"}},{"id":1455169,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-07-12T22:02:10.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2476,"price":1.18,"value":2921.68,"ownership":{"direct":true},"balance_after":32196,"source":{"system":"sec-edgar","filing":"0001520138-24-000241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000241/ownership.xml","form_type":"4"}},{"id":1455168,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-07-12T22:02:10.000Z","date":"2023-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2476,"price":5.51,"value":13642.76,"ownership":{"direct":true},"balance_after":34672,"source":{"system":"sec-edgar","filing":"0001520138-24-000241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000241/ownership.xml","form_type":"4"}},{"id":1455177,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-12T22:01:48.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":99000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal annual installments beginning on June 24, 2024."}],"balance_after":99000,"derivative":{"exercise_price":0.474,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":99000},"source":{"system":"sec-edgar","filing":"0001520138-24-000240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000240/ownership.xml","form_type":"4"}},{"id":1455176,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-12T22:01:48.000Z","date":"2024-06-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":18250,"price":0.474,"value":8650.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024."}],"balance_after":93940,"source":{"system":"sec-edgar","filing":"0001520138-24-000240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000240/ownership.xml","form_type":"4"}},{"id":1455175,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-12T22:01:48.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":73000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024."}],"balance_after":112196,"source":{"system":"sec-edgar","filing":"0001520138-24-000240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000240/ownership.xml","form_type":"4"}},{"id":1455174,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-12T22:01:48.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2476,"price":1.18,"value":2921.68,"ownership":{"direct":true},"balance_after":39196,"source":{"system":"sec-edgar","filing":"0001520138-24-000240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000240/ownership.xml","form_type":"4"}},{"id":1455173,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-12T22:01:48.000Z","date":"2023-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2476,"price":5.51,"value":13642.76,"ownership":{"direct":true},"balance_after":41672,"source":{"system":"sec-edgar","filing":"0001520138-24-000240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000240/ownership.xml","form_type":"4"}},{"id":1455275,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-12T22:01:05.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":227000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal annual installments beginning on June 24, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":227000,"derivative":{"exercise_price":0.474,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":227000},"source":{"system":"sec-edgar","filing":"0001520138-24-000239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013824000239/ownership.xml","form_type":"4"}},{"id":1455274,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-12T22:01:05.000Z","date":"2024-06-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":42000,"price":0.474,"value":19908.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":551948,"source":{"system":"sec-edgar","filing":"0001520138-24-000239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013824000239/ownership.xml","form_type":"4"}},{"id":1455273,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-12T22:01:05.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":593948,"source":{"system":"sec-edgar","filing":"0001520138-24-000239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013824000239/ownership.xml","form_type":"4"}},{"id":1455272,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-12T22:01:05.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4953,"price":1.18,"value":5844.54,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":425948,"source":{"system":"sec-edgar","filing":"0001520138-24-000239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013824000239/ownership.xml","form_type":"4"}},{"id":1455271,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock","published_at":"2024-07-12T22:01:05.000Z","date":"2023-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":4953,"price":5.51,"value":27291.03,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":430901,"source":{"system":"sec-edgar","filing":"0001520138-24-000239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013824000239/ownership.xml","form_type":"4"}},{"id":1591555,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Warrants (right to buy)","published_at":"2024-03-06T22:12:41.000Z","date":"2024-03-04","kind":"purchase","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $1.00 in connection with the issuer's public offering that closed on March 6, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":5000,"derivative":{"exercise_price":1.5,"exercise_date":"2024-03-04","expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520138-24-000099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013824000099/ownership.xml","form_type":"4"}},{"id":1591554,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock","published_at":"2024-03-06T22:12:41.000Z","date":"2024-03-04","kind":"purchase","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $1.00 in connection with the issuer's public offering that closed on March 6, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":435854,"source":{"system":"sec-edgar","filing":"0001520138-24-000099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013824000099/ownership.xml","form_type":"4"}},{"id":1712131,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-13T22:15:16.000Z","date":"2023-12-11","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44148,"source":{"system":"sec-edgar","filing":"0001520138-23-000547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000547/ownership.xml","form_type":"4"}},{"id":1719805,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-06T21:16:46.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":93500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting."}],"balance_after":93500,"derivative":{"exercise_price":3.01,"expiration_date":"2028-11-09","underlying":"Common Stock","underlying_shares":93500},"source":{"system":"sec-edgar","filing":"0001520138-23-000535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000535/ownership.xml","form_type":"4"}},{"id":1719851,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-06T21:15:42.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":42254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting."}],"balance_after":42254,"source":{"system":"sec-edgar","filing":"0001520138-23-000532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000152013823000532/ownership.xml","form_type":"4"}},{"id":1720348,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":107721,"kind":"person","name":"GORLIN STEVE","position":1,"cik":"0001033742","reported_name":"GORLIN STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-06T16:16:27.000Z","date":"2023-12-01","kind":"sale","planned":false,"acquired":false,"shares":75680,"price":1.69,"value":127899.2,"ownership":{"direct":true},"balance_after":46358,"source":{"system":"sec-edgar","filing":"0001520138-23-000534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1033742/000152013823000534/ownership.xml","form_type":"4"}},{"id":1720347,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":107721,"kind":"person","name":"GORLIN STEVE","position":1,"cik":"0001033742","reported_name":"GORLIN STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-06T16:16:27.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":46358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting."}],"balance_after":122038,"source":{"system":"sec-edgar","filing":"0001520138-23-000534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033742/000152013823000534/ownership.xml","form_type":"4"}},{"id":1720302,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69700,"kind":"person","name":"ROGICH SIGMUND","position":1,"cik":"0001168218","reported_name":"ROGICH SIGMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-06T16:16:06.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":42254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting."}],"balance_after":42254,"source":{"system":"sec-edgar","filing":"0001520138-23-000533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168218/000152013823000533/ownership.xml","form_type":"4"}},{"id":1720131,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69667,"kind":"person","name":"Sherman Michael Edward","position":1,"cik":"0001730468","reported_name":"Sherman Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-06T16:15:25.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":89750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting."}],"balance_after":89750,"derivative":{"exercise_price":3.01,"expiration_date":"2028-11-09","underlying":"Common Stock","underlying_shares":89750},"source":{"system":"sec-edgar","filing":"0001520138-23-000531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730468/000152013823000531/ownership.xml","form_type":"4"}},{"id":1720345,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-06T16:15:04.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":51830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 22, 2023, the reporting person filed a Form 4 which inadvertently reported that, following his exercise of an option and sale of the underlying stock, he directly owned 16,789 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person directly owned 17,405 shares of common stock."}],"balance_after":69235,"source":{"system":"sec-edgar","filing":"0001520138-23-000530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000152013823000530/ownership.xml","form_type":"4"}},{"id":1725357,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock","published_at":"2023-12-01T23:26:32.000Z","date":"2023-11-30","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.78,"value":17800.0,"ownership":{"direct":true},"balance_after":68759,"source":{"system":"sec-edgar","filing":"0001520138-23-000522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013823000522/ownership.xml","form_type":"4"}},{"id":1786176,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":107721,"kind":"person","name":"GORLIN STEVE","position":1,"cik":"0001033742","reported_name":"GORLIN STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-07T18:20:28.000Z","date":"2023-09-05","kind":"sale","planned":false,"acquired":false,"shares":8560,"price":3.05,"value":26108.0,"ownership":{"direct":true},"balance_after":75680,"source":{"system":"sec-edgar","filing":"0001520138-23-000371","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033742/000152013823000371/ownership.xml","form_type":"4"}},{"id":1797986,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-24T20:33:04.000Z","date":"2023-08-22","kind":"sale","planned":false,"acquired":false,"shares":10805,"price":3.5009,"value":37827.2245,"ownership":{"direct":true},"balance_after":16789,"source":{"system":"sec-edgar","filing":"0001520138-23-000347","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000152013823000347/ownership.xml","form_type":"4"}},{"id":1839306,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-04T00:49:33.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 20% on grand date in four equal annual installments beginning on June 7, 2024 (the first anniversary of the grant date)."}],"balance_after":20000,"derivative":{"exercise_price":5.78,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001520138-23-000277","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000277/ownership.xml","form_type":"4"}},{"id":1839607,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-04T00:47:07.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal annual installments beginning on June 29, 2024 (the first anniversary of the grant date)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":175000,"derivative":{"exercise_price":4.0953,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001520138-23-000275","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013823000275/ownership.xml","form_type":"4"}},{"id":1839606,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-07-04T00:47:07.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":149500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":425854,"source":{"system":"sec-edgar","filing":"0001520138-23-000275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013823000275/ownership.xml","form_type":"4"}},{"id":1839307,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-04T00:45:37.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 20% at grant date and in four equal annual installments beginning on June 7, 2024 (the first anniversary of the grant date)."}],"balance_after":30000,"derivative":{"exercise_price":5.78,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001520138-23-000273","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000273/ownership.xml","form_type":"4"}},{"id":1844172,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted stock units","published_at":"2023-06-26T20:06:00.000Z","date":"2023-06-21","kind":"exercise","planned":false,"acquired":false,"shares":41506,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on June 21, 2022 and vest ratably over a three-year period on each anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on June 21, 2022 and vest ratably over a three-year period on each anniversary of the grant date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":83014,"derivative":{"underlying":"Common Stock","underlying_shares":41506},"source":{"system":"sec-edgar","filing":"0001520138-23-000269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013823000269/ownership.xml","form_type":"4"}},{"id":1844171,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-06-26T20:06:00.000Z","date":"2023-06-21","kind":"exercise","planned":false,"acquired":true,"shares":41506,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":271401,"source":{"system":"sec-edgar","filing":"0001520138-23-000269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013823000269/ownership.xml","form_type":"4"}},{"id":1854753,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T17:15:40.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":5984,"price":5.8125,"value":34782.0,"ownership":{"direct":true},"balance_after":23210,"source":{"system":"sec-edgar","filing":"0001520138-23-000264","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000152013823000264/ownership.xml","form_type":"4"}},{"id":1854752,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T17:15:40.000Z","date":"2023-05-22","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":6.5012,"value":32506.0,"ownership":{"direct":true},"balance_after":29194,"source":{"system":"sec-edgar","filing":"0001520138-23-000264","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000152013823000264/ownership.xml","form_type":"4"}},{"id":1923995,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-04-06T21:02:56.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":2613,"price":8.52,"value":22262.76,"ownership":{"direct":true},"balance_after":34194,"source":{"system":"sec-edgar","filing":"0001520138-23-000187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000152013823000187/ownership.xml","form_type":"4"}},{"id":1923994,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-04-06T21:02:56.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":8.5215,"value":42607.5,"ownership":{"direct":true},"balance_after":36807,"source":{"system":"sec-edgar","filing":"0001520138-23-000187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000152013823000187/ownership.xml","form_type":"4"}},{"id":1923993,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-04-06T21:02:56.000Z","date":"2023-03-27","kind":"sale","planned":false,"acquired":false,"shares":3371,"price":8.517,"value":28710.807,"ownership":{"direct":true},"balance_after":41807,"source":{"system":"sec-edgar","filing":"0001520138-23-000187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000152013823000187/ownership.xml","form_type":"4"}},{"id":1998666,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"COMMON STOCK","published_at":"2023-02-23T00:31:16.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":2476,"price":6.12,"value":15153.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction code F - Payment of tax liability by withholding securities incident to the receipt"}],"balance_after":37148,"source":{"system":"sec-edgar","filing":"0001520138-23-000115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000115/ownership.xml","form_type":"4"}},{"id":1999719,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"COMMON STOCK","published_at":"2023-02-22T22:49:21.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":4953,"price":6.12,"value":30312.36,"ownership":{"direct":false,"nature":"SEE FOOTNOTE"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction code F - Payment of tax liability by withholding securities incident to the receipt"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":229895,"source":{"system":"sec-edgar","filing":"0001520138-23-000112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013823000112/ownership.xml","form_type":"4"}},{"id":1998665,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2023-02-22T22:49:19.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":2476,"price":6.12,"value":15153.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction code F - Payment of tax liability by withholding securities incident to the receipt"}],"balance_after":39148,"source":{"system":"sec-edgar","filing":"0001520138-23-000113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000113/ownership.xml","form_type":"4"}},{"id":1998663,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":116586,"kind":"person","name":"MARKHAM PENELOPE","position":1,"cik":"0001770555","reported_name":"MARKHAM PENELOPE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Liver Cirrhosis R&D"}}],"security":"COMMON STOCK","published_at":"2023-02-22T22:47:39.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":2476,"price":6.12,"value":15153.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction code F - Payment of tax liability by withholding securities incident to the receipt"}],"balance_after":47841,"source":{"system":"sec-edgar","filing":"0001520138-23-000109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000109/ownership.xml","form_type":"4"}},{"id":2000318,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":116631,"kind":"person","name":"Ahlem Clarence N.","position":1,"cik":"0001884599","reported_name":"Ahlem Clarence N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Neuroscience Product Dev."}}],"security":"COMMON STOCK","published_at":"2023-02-22T17:48:14.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":2476,"price":6.12,"value":15153.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction code F - Payment of tax liability by withholding securities incident to the receipt"}],"balance_after":37148,"source":{"system":"sec-edgar","filing":"0001520138-23-000111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1884599/000152013823000111/ownership.xml","form_type":"4"}},{"id":1999208,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":116598,"kind":"person","name":"READING CHRISTOPHER","position":1,"cik":"0001239658","reported_name":"READING CHRISTOPHER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Neuroscience R&D"}}],"security":"COMMON STOCK","published_at":"2023-02-22T17:47:56.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":2476,"price":6.12,"value":15153.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction code F - Payment of tax liability by withholding securities incident to the receipt"}],"balance_after":37148,"source":{"system":"sec-edgar","filing":"0001520138-23-000110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239658/000152013823000110/ownership.xml","form_type":"4"}},{"id":2052093,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-01-18T21:25:09.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":43578,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":68622,"source":{"system":"sec-edgar","filing":"0001520138-23-000059","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000059/ownership.xml","form_type":"4"}},{"id":2052129,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-01-18T21:24:01.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":34240,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34240,"source":{"system":"sec-edgar","filing":"0001520138-23-000057","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000152013823000057/ownership.xml","form_type":"4"}},{"id":2052092,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18655,"kind":"person","name":"Palumbo Joseph M","position":1,"cik":"0001892610","reported_name":"Palumbo Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"COMMON STOCK","published_at":"2023-01-18T21:23:25.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":39624,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39624,"source":{"system":"sec-edgar","filing":"0001520138-23-000056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000056/ownership.xml","form_type":"4"}},{"id":2052091,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":18653,"kind":"person","name":"KIM JOANNE WENDY","position":1,"cik":"0001771317","reported_name":"KIM JOANNE WENDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2023-01-18T21:21:22.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":39624,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41624,"source":{"system":"sec-edgar","filing":"0001520138-23-000052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000052/ownership.xml","form_type":"4"}},{"id":2052394,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":12723,"kind":"person","name":"DO CUONG V","position":1,"cik":"0001477037","reported_name":"DO CUONG V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"COMMON STOCK","published_at":"2023-01-18T21:20:59.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":79248,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"SEE FOOTNOTE"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities are held in the name of Do & Rickles Investments LLC."}],"balance_after":234848,"source":{"system":"sec-edgar","filing":"0001520138-23-000051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477037/000152013823000051/ownership.xml","form_type":"4"}},{"id":2052090,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":116586,"kind":"person","name":"MARKHAM PENELOPE","position":1,"cik":"0001770555","reported_name":"MARKHAM PENELOPE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Liver Cirrhosis R&D"}}],"security":"COMMON STOCK","published_at":"2023-01-18T21:20:01.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":39624,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50317,"source":{"system":"sec-edgar","filing":"0001520138-23-000050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000050/ownership.xml","form_type":"4"}},{"id":2052779,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69700,"kind":"person","name":"ROGICH SIGMUND","position":1,"cik":"0001168218","reported_name":"ROGICH SIGMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2023-01-18T16:55:51.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in four equal installments over a one-year period ending November 9, 2023."}],"balance_after":55000,"derivative":{"exercise_price":6.12,"expiration_date":"2032-11-23","underlying":"COMMON STOCK","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001520138-23-000062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168218/000152013823000062/ownership.xml","form_type":"4"}},{"id":2052850,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":107721,"kind":"person","name":"GORLIN STEVE","position":1,"cik":"0001033742","reported_name":"GORLIN STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-01-18T16:32:13.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":34240,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":84240,"source":{"system":"sec-edgar","filing":"0001520138-23-000061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033742/000152013823000061/ownership.xml","form_type":"4"}},{"id":2052539,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":69667,"kind":"person","name":"Sherman Michael Edward","position":1,"cik":"0001730468","reported_name":"Sherman Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2023-01-18T16:25:55.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in four equal installments over a one-year period ending November 9, 2023."}],"balance_after":75000,"derivative":{"exercise_price":6.12,"expiration_date":"2032-11-23","underlying":"COMMON STOCK","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001520138-23-000060","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730468/000152013823000060/ownership.xml","form_type":"4"}},{"id":2052214,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":116598,"kind":"person","name":"READING CHRISTOPHER","position":1,"cik":"0001239658","reported_name":"READING CHRISTOPHER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Neuroscience R&D"}}],"security":"COMMON STOCK","published_at":"2023-01-18T16:24:21.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":39624,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39624,"source":{"system":"sec-edgar","filing":"0001520138-23-000058","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239658/000152013823000058/ownership.xml","form_type":"4"}},{"id":2052740,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":116631,"kind":"person","name":"Ahlem Clarence N.","position":1,"cik":"0001884599","reported_name":"Ahlem Clarence N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Neuroscience Product Dev."}}],"security":"COMMON STOCK","published_at":"2023-01-18T16:22:48.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":39624,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39624,"source":{"system":"sec-edgar","filing":"0001520138-23-000055","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1884599/000152013823000055/ownership.xml","form_type":"4"}},{"id":2052815,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-01-18T16:22:22.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":43578,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45178,"source":{"system":"sec-edgar","filing":"0001520138-23-000054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000152013823000054/ownership.xml","form_type":"4"}},{"id":2053110,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2023-01-18T16:21:52.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in four equal installments over a one-year period ending November 9, 2023."}],"balance_after":65000,"derivative":{"exercise_price":6.12,"expiration_date":"2032-11-23","underlying":"COMMON STOCK","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001520138-23-000053","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013823000053/ownership.xml","form_type":"4"}},{"id":2173325,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-08-26T17:10:53.000Z","date":"2020-09-22","kind":"exercise","acquired":false,"shares":299750,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"Exercisable at the lower of $4 (adjusted to reflect the Reverse Stock Split) or 80% of the offering price to the public in the Uplisting Offering."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":0,"derivative":{"exercise_date":"2020-07-13","expiration_date":"2025-07-13","underlying":"Common Stock","underlying_shares":299750},"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173324,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-08-26T17:10:53.000Z","date":"2020-09-22","kind":"exercise","acquired":false,"shares":1250000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"Exercisable at the lower of $4 (adjusted to reflect the Reverse Stock Split) or 80% of the offering price to the public in the Uplisting Offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"See Exhibit 99.1"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":0,"derivative":{"exercise_date":"2019-11-22","expiration_date":"2024-09-24","underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173323,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"10% Convertible Debenture due 2020","published_at":"2022-08-26T17:10:53.000Z","date":"2020-09-22","kind":"disposition_to_issuer","acquired":false,"price":0,"reported_value":2000000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"On September 22, 2020, the Issuer paid approximately $1.8 million to Acuitas satisfy all amounts owed on the Debenture due September 24, 2020."},{"field":"kind","element":"transactionCoding","label":"F12","text":"On September 22, 2020, the Issuer paid approximately $1.8 million to Acuitas satisfy all amounts owed on the Debenture due September 24, 2020."},{"field":"reported_value","element":"transactionTotalValue","label":"F6","text":"See Exhibit 99.1"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":0,"derivative":{"exercise_date":"2019-12-01","expiration_date":"2020-09-24","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173322,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-08-26T17:10:53.000Z","date":"2020-07-13","kind":"grant","acquired":true,"shares":299750,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"See Exhibit 99.1"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"Exercisable at the lower of $4 (adjusted to reflect the Reverse Stock Split) or 80% of the offering price to the public in the Uplisting Offering."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":299750,"derivative":{"exercise_date":"2020-07-13","expiration_date":"2025-07-13","underlying":"Common Stock","underlying_shares":299750},"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173321,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-08-26T17:10:53.000Z","date":"2019-09-24","kind":"grant","acquired":true,"shares":1250000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"See Exhibit 99.1"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"Exercisable at the lower of $4 (adjusted to reflect the Reverse Stock Split) or 80% of the offering price to the public in the Uplisting Offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"See Exhibit 99.1"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":1250000,"derivative":{"exercise_date":"2019-11-22","expiration_date":"2024-09-24","underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173320,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"10% Convertible Debenture due 2020","published_at":"2022-08-26T17:10:53.000Z","date":"2019-09-24","kind":"grant","acquired":true,"reported_value":2000000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"See Exhibit 99.1"},{"field":"reported_value","element":"transactionTotalValue","label":"F6","text":"See Exhibit 99.1"},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"See Exhibit 99.1"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"See Exhibit 99.1"},{"field":"valueOwnedAfter","element":"valueOwnedFollowingTransaction","label":"F6","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"derivative":{"exercise_date":"2019-12-01","expiration_date":"2020-09-24","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173319,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-08-26T17:10:53.000Z","date":"2019-06-24","kind":"disposition_to_issuer","acquired":false,"shares":1713331,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Pursuant to a letter agreement with the Issuer dated June 24, 2019, Acuitas agreed to modify its existing rights under the 2018 SPA and agreed to immediately exchange the 2018 Warrants such that it effectively exercised its warrant in full pursuant to a cashless exercise thereof at an assumed then-current market price of $45 per share (adjusted to reflect the Reverse Stock Split) and, as a result, received an aggregate of 95% of the shares covered thereby."},{"field":"date","element":"transactionDate","label":"F5","text":"Pursuant to a letter agreement with the Issuer dated June 24, 2019, Acuitas agreed to modify its existing rights under the 2018 SPA and agreed to immediately exchange the 2018 Warrants such that it effectively exercised its warrant in full pursuant to a cashless exercise thereof at an assumed then-current market price of $45 per share (adjusted to reflect the Reverse Stock Split) and, as a result, received an aggregate of 95% of the shares covered thereby."},{"field":"shares","element":"transactionShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to a letter agreement with the Issuer dated June 24, 2019, Acuitas agreed to modify its existing rights under the 2018 SPA and agreed to immediately exchange the 2018 Warrants such that it effectively exercised its warrant in full pursuant to a cashless exercise thereof at an assumed then-current market price of $45 per share (adjusted to reflect the Reverse Stock Split) and, as a result, received an aggregate of 95% of the shares covered thereby."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":0,"derivative":{"exercise_date":"2018-07-03","expiration_date":"2024-07-03","underlying":"Common Stock","underlying_shares":1713331},"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173318,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2022-08-26T17:10:53.000Z","date":"2018-08-03","kind":"exercise","acquired":false,"shares":1600000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"See Exhibit 99.1"},{"field":"date","element":"transactionDate","label":"F1","text":"See Exhibit 99.1"},{"field":"shares","element":"transactionShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"See Exhibit 99.1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"See Exhibit 99.1"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"See Exhibit 99.1"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1600000},"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173317,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-08-26T17:10:53.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":1713331,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"See Exhibit 99.1"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":1713331,"derivative":{"exercise_price":2.25,"exercise_date":"2018-07-03","expiration_date":"2024-07-03","underlying":"Common Stock","underlying_shares":1713331},"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173316,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2022-08-26T17:10:53.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":1600000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"See Exhibit 99.1"},{"field":"shares","element":"transactionShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"See Exhibit 99.1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"See Exhibit 99.1"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"See Exhibit 99.1"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Adjusted to reflect the 125-for-1 reverse stock split effectuated by the Issuer on November 22, 2019 (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":1600000,"derivative":{"underlying":"Common Stock","underlying_shares":1600000},"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173315,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T17:10:53.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":8361308,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Issuer issued these shares to NeurMedix, Inc. (\"NeurMedix\") in partial consideration for the acquisition of certain assets from NeurMedix and the assumption of certain liabilities of NeurMedix pursuant to the Asset Purchase Agreement, dated April 27, 2021, by and among the Issuer, NeurMedix, Inc. and Acuitas. In connection with the closing, NeurMedix assigned the rights to receive such shares to Acuitas."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":19529846,"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}},{"id":2173314,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":78208,"kind":"person","name":"PEIZER TERREN S","position":1,"cik":"0000904534","reported_name":"PEIZER TERREN S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T17:10:53.000Z","date":"2020-09-22","kind":"exercise","acquired":true,"shares":1549750,"price":0.0001,"value":154.975,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Acuitas Group Holdings, LLC (\"Acuitas\"), is an entity beneficially owned and controlled by Terren S. Peizer."}],"balance_after":11168538,"source":{"system":"sec-edgar","filing":"0001520138-22-000381","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/904534/000152013822000381/ownership.xml","form_type":"4"}}],"next_cursor":"2022-08-26T17:10:53.000000Z,2173314"}